Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cartesian Therapeutics, Inc. RNAC

Full chart Compare
Set alert

Price alert · RNAC

All alert types
6.41 USD +0.07 (+1.10%)

At closeNov 3, 2026, 4:00 PM EST

6.41 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

6.37 Day range 6.68
5.60 52-week range 11.00
YTD
-11.10%
1 year
-21.16%

Financial health

Altman Z-Score

-4.61 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.4×
FY 2016: -5.0×FY 2017: -3.1×FY 2018: -0.9×FY 2019: -2.0×FY 2020: -4.5×FY 2021: -14.5×FY 2022: 4.6×FY 2023: -0.4×FY 2024: -5.4×FY 2025: -1.4×
FY 2016 5y median -1.4× FY 2025
P/S 67.0×
FY 2016: 18.6×FY 2017: 807×FY 2018: 55.0×FY 2019: 13.5×FY 2020: 15.4×FY 2021: 3.7×FY 2022: 1.2×FY 2023: 3.9×FY 2024: 10.9×FY 2025: 67.0×
FY 2016 5y median 3.9× FY 2025
P/B -1.5×
FY 2016: 2.7×FY 2017: 3.2×FY 2018: -9.2×FY 2019: 10.8×FY 2020: -14.2×FY 2021: 13.8×FY 2022: 1.5×FY 2023: -0.2×FY 2024: -62.4×FY 2025: -1.5×
FY 2016 5y median -0.2× FY 2025
P/FCF -2.4×
FY 2016: -7.4×FY 2017: -3.2×FY 2018: -0.8×FY 2019: -1.8×FY 2020: 7.5×FY 2021: -5.1×FY 2022: -4.2×FY 2023: -2.0×FY 2024: -12.9×FY 2025: -2.4×
FY 2016 5y median -4.2× FY 2025
EV/EBITDA -0.5×
FY 2016: -3.0×FY 2017: -1.9×FY 2018: -0.5×FY 2019: -0.4×FY 2020: -2.3×FY 2021: -41.2×FY 2022: 1.7×FY 2023: -0.2×FY 2024: -3.0×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
EV/Sales 26.7×
FY 2016: 12.8×FY 2017: 567×FY 2018: 37.2×FY 2019: 2.9×FY 2020: 9.2×FY 2021: 2.7×FY 2022: 0.6×FY 2023: 1.4×FY 2024: 5.8×FY 2025: 26.7×
FY 2016 5y median 2.7× FY 2025
FCF Yield -42.4%
FY 2016: -13.5%FY 2017: -31.6%FY 2018: -121.0%FY 2019: -57.0%FY 2020: 13.3%FY 2021: -19.8%FY 2022: -24.1%FY 2023: -50.5%FY 2024: -7.7%FY 2025: -42.4%
FY 2016 5y median -24.1% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 98.2%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -3099.9%
FY 2016: -428.9%FY 2017: -30813.5%FY 2018: -7200.7%FY 2019: -785.6%FY 2020: -342.4%FY 2021: -5.4%FY 2022: 13.1%FY 2023: -332.3%FY 2024: -112.8%FY 2025: -3099.9%
FY 2016 5y median -112.8% FY 2025
Net Margin -4658.6%
FY 2016: -448.0%FY 2017: -31556.0%FY 2018: -7235.4%FY 2019: -829.0%FY 2020: -415.0%FY 2021: -30.2%FY 2022: 31.9%FY 2023: -844.9%FY 2024: -199.0%FY 2025: -4658.6%
FY 2016 5y median -199.0% FY 2025
ROE 103.2%
FY 2016: -65.9%FY 2017: -126.1%FY 2018: 1205.9%FY 2019: -659.2%FY 2020: 382.5%FY 2021: -114.1%FY 2022: 37.7%FY 2023: 49.9%FY 2024: 1138.3%FY 2025: 103.2%
FY 2016 5y median 49.9% FY 2025
ROIC -28.4%
FY 2016: -43.5%FY 2017: -70.8%FY 2018: -211.6%FY 2019: -62.5%FY 2020: -67.0%FY 2021: -4.9%FY 2022: 9.6%FY 2023: -33.3%FY 2024: -10.6%FY 2025: -28.4%
FY 2016 5y median -10.6% FY 2025
ROA -44.0%
FY 2016: -40.5%FY 2017: -64.6%FY 2018: -146.9%FY 2019: -55.6%FY 2020: -41.6%FY 2021: -16.1%FY 2022: 21.3%FY 2023: -72.0%FY 2024: -17.8%FY 2025: -44.0%
FY 2016 5y median -17.8% FY 2025

Growth (YoY)

Revenue -92.8%
FY 2016: 34.5%FY 2017: -97.4%FY 2018: 336.2%FY 2019: 639.4%FY 2020: 148.6%FY 2021: 412.6%FY 2022: 30.2%FY 2023: -76.5%FY 2024: 49.6%FY 2025: -92.8%
FY 2016 FY 2025
Operating Income -97.5%
FY 2016: -37.0%FY 2017: -84.0%FY 2018: -1.9%FY 2019: 19.3%FY 2020: -8.3%FY 2021: 91.9%FY 2022: 416.2%FY 2023: -694.4%FY 2024: 49.2%FY 2025: -97.5%
FY 2016 FY 2025
EPS (diluted) -52.6%
FY 2016: -36.6%FY 2017: 7.3%FY 2018: 8.7%FY 2019: 58.4%FY 2020: 44.0%FY 2021: 67.7%FY 2022: 145.5%FY 2023: -1758.7%FY 2024: 93.4%FY 2025: -52.6%
FY 2016 FY 2025
Free Cash Flow -142.3%
FY 2016: 14.2%FY 2017: -160.3%FY 2018: -13.8%FY 2019: 14.3%FY 2020: 166.2%FY 2021: -280.4%FY 2022: 46.6%FY 2023: -56.5%FY 2024: 36.2%FY 2025: -142.3%
FY 2016 FY 2025

Financial Health

Current Ratio 8.7×
FY 2016: 6.3×FY 2017: 9.0×FY 2018: 1.2×FY 2019: 2.8×FY 2020: 1.9×FY 2021: 2.0×FY 2022: 5.9×FY 2023: 1.3×FY 2024: 9.4×FY 2025: 8.7×
FY 2016 5y median 5.9× FY 2025
Quick Ratio 8.7×
FY 2016: 6.3×FY 2017: 9.2×FY 2018: 1.2×FY 2019: 2.8×FY 2020: 1.9×FY 2021: 2.0×FY 2022: 5.9×FY 2023: 1.3×FY 2024: 9.4×FY 2025: 8.7×
FY 2016 5y median 5.9× FY 2025
Debt / Equity -0.1×
FY 2016: 0.2×FY 2017: 0.4×FY 2018: -3.9×FY 2019: 2.3×FY 2020: -2.0×FY 2021: 1.6×FY 2022: 0.4×FY 2023: -0.0×FY 2024: -2.1×FY 2025: -0.1×
FY 2016 5y median -0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: 1.4×FY 2017: 0.8×FY 2018: 0.3×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 14.0×FY 2022: -1.8×FY 2023: 0.3×FY 2024: 2.6×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2016: -27.7×FY 2017: -52.9×FY 2018: -43.5×FY 2019: -34.5×FY 2020: -36.5×FY 2021: -1.6×FY 2022: 4.8×FY 2023: -30.5×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31